Skip to main content
Clinical Trials/NL-OMON33348
NL-OMON33348
Not yet recruiting
Not Applicable

Mapping dopaminergic function using pharmacologic Magnetic Resonance Imaging (phMRI) in healthy subjects and users of amphetamine - MPH-MRI

Academisch Medisch Centrum0 sites20 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
drugsgebruik/verslaving
Sponsor
Academisch Medisch Centrum
Enrollment
20
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • Male. Between 18 and 35 years of age. Regular use of amphetamines (on more than 40 occasions the past year) for the amphetamine using group

Exclusion Criteria

  • Serious general medical condition or one that could interfere in the interpretation of results
  • \-use of (DA) medication within the last 2 weeks
  • \-excessive consumption of alcohol (\>21 units/ week), caffeine (greater than eight cups of coffee per day) or cigarettes (greater than ten cigarettes per day).
  • \-Contraindications for MRI (e.g. osteosynthetic material, pacemaker, artificial cardiac valves), claustrophobia

Outcomes

Primary Outcomes

Not specified

Similar Trials